Koers VioQuest Pharmaceuticals, Inc. Other OTC
Aandelen
VOQP
US9276252023
Biotechnologie & Medisch Onderzoek
Omzet 2006 | - | Omzet 2007 | - | Marktkapitalisatie | 5,46 mln. 5,11 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2006 | -8 mln. -7,49 mln. | Nettowinst (verlies) 2007 | -10 mln. -9,36 mln. | EV/omzet 2006 | - |
Nettoliquiditeiten 2006 | 2,67 mln. 2,5 mln. | Nettoschuld 2007 | 2,24 mln. 2,09 mln. | EV/omzet 2007 | - |
K/w-verhouding 2006 |
-2,5
x | K/w-verhouding 2007 |
-0,43
x | Werknemers | - |
Dividendrendement 2006 * |
-
| Dividendrendement 2007 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Mark D. Dacko
AUD | Comptroller/Controller/Auditor | 72 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | - | 09-02-09 | |
Mark D. Dacko
AUD | Comptroller/Controller/Auditor | 72 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,49% | 122 mld. | |
+21,73% | 115 mld. | |
+23,06% | 26,64 mld. | |
-21,81% | 19,91 mld. | |
-16,91% | 16,32 mld. | |
-18,81% | 15,49 mld. | |
-44,74% | 15,52 mld. | |
+62,72% | 14,83 mld. | |
+3,09% | 13,67 mld. |